From January 22, 2024 to March 31, 2024, the company has repurchased 1,150,000 shares, representing 0.86% for CNY 62.43 million. With this, the company has completed the repurchase of 1,150,000 shares, representing 0.86% for CNY 62.43 million under the buyback announced on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.63 CNY | -2.65% | -6.28% | -25.68% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.68% | 1.05B | |
-2.95% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+61.28% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.30% | 8.89B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on January 23, 2024.